Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy
Clinical trial NCT00935012 · COMPLETED
Trial details
- NCT number
- NCT00935012
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-30
- Primary completion
- 2019-11-20
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.